Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Capstone Therapeutics, LipimetiX form JV

Executive Summary

Cardiovascular/metabolic drug developer Capstone Therapeutics Corp. has formed a joint venture, LipimetiX Development LLC (LD), with LipimetiX LLC (commercializes IP discovered at the University of Alabama, Birmingham) to work on medications that lower blood cholesterol levels.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Joint Venture
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register